• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用F-FAPI-04和F-FAPI-42 PET/CT对癌症患者正常组织的生理摄取进行比较。

Comparison of physiological uptake of normal tissues in patients with cancer using F-FAPI-04 and F-FAPI-42 PET/CT.

作者信息

Mu Xingyu, Huang Xiaoxue, Li Meng, Sun Wenjie, Fu Wei

机构信息

Department of Nuclear Medicine, Affiliated Hospital, Guilin Medical University, Guilin, China.

出版信息

Front Nucl Med. 2022 Sep 29;2:927843. doi: 10.3389/fnume.2022.927843. eCollection 2022.

DOI:10.3389/fnume.2022.927843
PMID:39354982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11440963/
Abstract

PURPOSE

To calculate the physiological uptake of various tissues in patients with cancer using F-AlF-NOTA-FAPI-04 (F-FAPI-04) and F-AlF-NOTA-FAPI-42 (F-FAPI-42) PET/CT and to compare the variation in standard uptake values between the two scans.

MATERIALS AND METHODS

This retrospective analysis included 40 patients with cancer who underwent F-FAPI; the first 20 patients received F-FAPI-04 PET/CT and the remaining 20 patients received F-FAPI-42 PET/CT. A total of 49 normal tissues, including the brain (cerebrum/cerebellum), parotid and submandibular glands, palatine tonsils, and thyroid, were identified on CT images. For these normal tissues, maximum standardized uptake value (SUVmax) and mean standardized uptake value (SUVmean) were calculated. We also compared the SUVmean of identical tissues to explore the difference in biodistribution between the two radiotracers.

RESULTS

The accumulation of F-FAPI-04 and F-FAPI-42 showed an analogous pattern. High uptake of both radiotracers in the gallbladder, uterus, submandibular gland, and renal pelvis was demonstrated (range: SUVmax, 4.01-5.75; SUVmean, 2.92-4.22). Furthermore, the uptake of bony tissues was slightly higher in F-FAPI-42 than in F-FAPI-04 (range: SUVmean, 0.4 ± 0.22-0.9 ± 0.34 and 0.3 ± 0.24-0.7 ± 0.18, respectively, < 0.05), while the uptake of some soft tissues was higher in F-FAPI-04 than in F-FAPI-42 (range: SUVmean, 0.9 ± 0.24-1.5 ± 0.35 and 0.9 ± 0.26-1.2 ± 0.37, respectively, < 0.05).

CONCLUSIONS

Both radioligands exhibited similar physiological uptake of normal tissues in patients with cancers. In addition, F-FAPI-42 demonstrated higher uptake of bone tissues than F-FAPI-04 while showing lower uptake of soft tissues than F-FAPI-04.

摘要

目的

使用F-AlF-NOTA-FAPI-04(F-FAPI-04)和F-AlF-NOTA-FAPI-42(F-FAPI-42)PET/CT计算癌症患者各种组织的生理摄取量,并比较两次扫描之间标准摄取值的变化。

材料与方法

这项回顾性分析纳入了40例接受F-FAPI检查的癌症患者;前20例患者接受F-FAPI-04 PET/CT检查,其余20例患者接受F-FAPI-42 PET/CT检查。在CT图像上共识别出49个正常组织,包括脑(大脑/小脑)、腮腺和颌下腺、腭扁桃体和甲状腺。对于这些正常组织,计算最大标准化摄取值(SUVmax)和平均标准化摄取值(SUVmean)。我们还比较了相同组织的SUVmean,以探讨两种放射性示踪剂在生物分布上的差异。

结果

F-FAPI-04和F-FAPI-42的摄取表现出相似的模式。两种放射性示踪剂在胆囊、子宫、颌下腺和肾盂中均表现出高摄取(范围:SUVmax,4.01 - 5.75;SUVmean,2.92 - 4.22)。此外,F-FAPI-42对骨组织的摄取略高于F-FAPI-04(范围:SUVmean分别为0.4±0.22 - 0.9±0.34和0.3±0.24 - 0.7±0.18,P<0.05),而F-FAPI-04对一些软组织的摄取高于F-FAPI-42(范围:SUVmean分别为0.9±0.24 - 1.5±0.35和0.9±0.26 - 1.2±0.37,P<0.05)。

结论

两种放射性配体在癌症患者的正常组织中均表现出相似的生理摄取。此外,F-FAPI-42对骨组织的摄取高于F-FAPI-04,而对软组织的摄取低于F-FAPI-04。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1299/11440963/20913811f153/fnume-02-927843-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1299/11440963/96e74e03c15a/fnume-02-927843-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1299/11440963/ced5609b4542/fnume-02-927843-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1299/11440963/20913811f153/fnume-02-927843-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1299/11440963/96e74e03c15a/fnume-02-927843-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1299/11440963/ced5609b4542/fnume-02-927843-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1299/11440963/20913811f153/fnume-02-927843-g0003.jpg

相似文献

1
Comparison of physiological uptake of normal tissues in patients with cancer using F-FAPI-04 and F-FAPI-42 PET/CT.使用F-FAPI-04和F-FAPI-42 PET/CT对癌症患者正常组织的生理摄取进行比较。
Front Nucl Med. 2022 Sep 29;2:927843. doi: 10.3389/fnume.2022.927843. eCollection 2022.
2
Value of [F]AlF-NOTA-FAPI-04 PET/CT for differential diagnosis of malignant and various inflammatory lung lesions: comparison with [F]FDG PET/CT.^18^F-AlF-NOTA-FAPI-04 PET/CT 对良恶性及各种肺部炎性病变的鉴别诊断价值:与^18^F-FDG PET/CT 的比较。
Eur Radiol. 2024 Mar;34(3):1948-1959. doi: 10.1007/s00330-023-10208-y. Epub 2023 Sep 5.
3
[F] AlF-NOTA-FAPI-04 PET/CT for non-invasive assessment of tubular injury in kidney diseases.[F] 用于肾脏疾病肾小管损伤无创评估的AlF-NOTA-FAPI-04正电子发射断层显像/计算机断层扫描(PET/CT)
Clin Kidney J. 2024 Mar 14;17(5):sfae064. doi: 10.1093/ckj/sfae064. eCollection 2024 May.
4
Physiological tracer distribution and benign lesion incidental uptake of Al18F-NOTA-FAPI-04 on PET/CT imaging.生理示踪剂分布与 Al18F-NOTA-FAPI-04 在 PET/CT 成像中的良性病变偶然摄取。
Nucl Med Commun. 2022 Jul 1;43(7):847-854. doi: 10.1097/MNM.0000000000001563. Epub 2022 May 4.
5
Head-to-head intra-individual comparison of biodistribution and tumor uptake of Ga-FAPI and F-FDG PET/CT in cancer patients.头对头个体内比较 Ga-FAPI 和 F-FDG PET/CT 在癌症患者中的生物分布和肿瘤摄取。
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4377-4385. doi: 10.1007/s00259-021-05307-1. Epub 2021 Jun 17.
6
Ga-FAPI-PET/CT in patients with various gynecological malignancies.镓标记的成纤维细胞活化蛋白抑制剂正电子发射断层扫描/计算机断层扫描在各种妇科恶性肿瘤患者中的应用
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):4089-4100. doi: 10.1007/s00259-021-05378-0. Epub 2021 May 29.
7
Clinical application of AlF-NOTA-FAPI PET/CT in diagnosis and TNM staging of pancreatic adenocarcinoma, compared to F-FDG.AlF-NOTA-FAPI PET/CT 在胰腺腺癌诊断和 TNM 分期中的临床应用,与 F-FDG 相比。
Cancer Imaging. 2023 Sep 12;23(1):86. doi: 10.1186/s40644-023-00596-1.
8
[F]AlF-NOTA-FAPI-04 PET/CT uptake in metastatic lesions on PET/CT imaging might distinguish different pathological types of lung cancer.[F]氟代阿尔伐斯汀环丙基非肽类 FAPI-04 正电子发射断层扫描/计算机断层扫描(PET/CT)摄取在转移灶的 PET/CT 成像上可能有助于鉴别不同病理类型的肺癌。
Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1671-1681. doi: 10.1007/s00259-021-05638-z. Epub 2021 Dec 6.
9
Comparative assessment of the diagnostic efficacy of [F]AlF-NOTA-FAPI-04 and [F]FDG PET/CT imaging for detecting postoperative recurrence in gastric cancer patients: a pilot study.[F]AlF-NOTA-FAPI-04与[F]FDG PET/CT成像检测胃癌患者术后复发的诊断效能比较评估:一项初步研究。
Front Oncol. 2024 Sep 11;14:1427649. doi: 10.3389/fonc.2024.1427649. eCollection 2024.
10
Clinical value of [F]AlF-NOTA-FAPI-04 PET/CT for assessing early-stage liver fibrosis in adult liver transplantation recipients compared with chronic HBV patients.[F]AlF-NOTA-FAPI-04 PET/CT 在评估成人肝移植受者与慢性 HBV 患者早期肝纤维化中的临床价值。
Jpn J Radiol. 2024 May;42(5):536-545. doi: 10.1007/s11604-024-01528-0. Epub 2024 Feb 6.

引用本文的文献

1
Impact of fat intake on [F]AlF-NOTA-FAPI-04 uptake in normal abdominal organs.脂肪摄入量对正常腹部器官中[F]AlF-NOTA-FAPI-04摄取的影响。
Front Med (Lausanne). 2024 Nov 7;11:1464779. doi: 10.3389/fmed.2024.1464779. eCollection 2024.

本文引用的文献

1
Preclinical evaluation and pilot clinical study of [F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts.用于癌症相关成纤维细胞PET成像的[F]AlF标记FAPI示踪剂的临床前评估和初步临床研究。
Acta Pharm Sin B. 2022 Feb;12(2):867-875. doi: 10.1016/j.apsb.2021.09.032. Epub 2021 Oct 15.
2
[F]FAPI-42 PET imaging in cancer patients: optimal acquisition time, biodistribution, and comparison with [Ga]Ga-FAPI-04.[F]FAPI-42 PET 成像在癌症患者中的应用:最佳采集时间、生物分布及与[Ga]Ga-FAPI-04 的比较。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2833-2843. doi: 10.1007/s00259-021-05646-z. Epub 2021 Dec 11.
3
FAPI-04 Uptake in Healthy Tissues of Cancer Patients in Ga-FAPI-04 PET/CT Imaging.
在 Ga-FAPI-04 PET/CT 成像中,癌症患者健康组织中的 FAPI-04 摄取。
Contrast Media Mol Imaging. 2021 Nov 23;2021:9750080. doi: 10.1155/2021/9750080. eCollection 2021.
4
Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary Staging in Lung Adenocarcinoma: a Prospective Study.F-18 标记成纤维细胞激活蛋白抑制剂(FAPI)在肺腺癌原发分期中的临床应用:一项前瞻性研究。
Mol Imaging Biol. 2022 Apr;24(2):309-320. doi: 10.1007/s11307-021-01679-w. Epub 2021 Nov 23.
5
FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?FAP和FAPI-PET/CT在恶性和非恶性疾病中的应用:完美共生?
Cancers (Basel). 2021 Sep 30;13(19):4946. doi: 10.3390/cancers13194946.
6
Comparison of 18F-AlF-NOTA-FAPI and 18F-FDG Imaging in a Patient With Gastric Signet-Ring Cell Carcinoma.18F-AlF-NOTA-FAPI 与 18F-FDG 成像在胃印戒细胞癌患者中的比较。
Clin Nucl Med. 2021 Nov 1;46(11):929-930. doi: 10.1097/RLU.0000000000003742.
7
Clinical translational evaluation of AlF-NOTA-FAPI for fibroblast activation protein-targeted tumour imaging.AlF-NOTA-FAPI 用于成纤维细胞激活蛋白靶向肿瘤成像的临床转化评估。
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4259-4271. doi: 10.1007/s00259-021-05470-5. Epub 2021 Jun 24.
8
Head-to-head intra-individual comparison of biodistribution and tumor uptake of Ga-FAPI and F-FDG PET/CT in cancer patients.头对头个体内比较 Ga-FAPI 和 F-FDG PET/CT 在癌症患者中的生物分布和肿瘤摄取。
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4377-4385. doi: 10.1007/s00259-021-05307-1. Epub 2021 Jun 17.
9
Ga-FAPI-PET/CT in patients with various gynecological malignancies.镓标记的成纤维细胞活化蛋白抑制剂正电子发射断层扫描/计算机断层扫描在各种妇科恶性肿瘤患者中的应用
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):4089-4100. doi: 10.1007/s00259-021-05378-0. Epub 2021 May 29.
10
FAPI-04 PET/CT Using [F]AlF Labeling Strategy: Automatic Synthesis, Quality Control, and Assessment in Patient.采用[F]AlF标记策略的FAPI-04 PET/CT:自动合成、质量控制及患者评估
Front Oncol. 2021 Mar 19;11:649148. doi: 10.3389/fonc.2021.649148. eCollection 2021.